7-Epi 10-desacetyl paclitaxel
CAS: 78454-17-8
Ref. 3D-IE22703
| 5mg | 286.00 € | ||
| 10mg | 420.00 € | ||
| 25mg | 598.00 € | ||
| 50mg | 854.00 € | ||
| 100mg | 1,339.00 € |
Product Information
- 10-Deacetyl-7-epi-taxol10-Deacetyl-7-epitaxol10-Desacetyl-7-epipaclitaxelPaclitaxel related compound B
- 7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.
- 7-EPI-10-DEACETYL-TAXOL
- Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, (2aR,4R,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-
- 7-Epi-10-deacetyltaxol
- 7-epi-10-Deacetyltaxol
- 2'-epi-3'-epi-10-Deacetyltaxol
- 10-Deacetyl-7-epitaxol
7-Epi 10-desacetyl paclitaxel is a prodrug of paclitaxel. It has a similar mechanism of action to paclitaxel, and is used as a chemotherapeutic agent for the treatment of cancer. 7-Epi 10-desacetyl paclitaxel has shown potent apoptotic activity in cell culture, as well as in animal models. This drug is prepared by high performance liquid chromatography and is used to treat cancer. The drug may also be activated by an enzyme called adenosine diphosphate ribose (ADPR), which forms from ATP during cellular metabolism. 7-Epi 10-desacetyl paclitaxel may also have anticancer effects on cervical cancer cells due to its ability to inhibit the synthesis of DNA and RNA.
Chemical properties
Technical inquiry about: 3D-IE22703 7-Epi 10-desacetyl paclitaxel
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
